Isosorbide

Isosorbide

SCHEMBL9915547

OC1COC2C1OC[C@H]2O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 1.00
▸ LMNA P02545 1/20 1.00
▸ MAPT P10636 1/20 0.48
▸ BCHE P06276 1/20 0.33
▸ FUCA1 P04066 1/20 0.30
▸ GBA1 P04062 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isosorbide SCHEMBL822850 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL83297 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL824823 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL12504733 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL5884995 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL24465084 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL9915550 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL2599531 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL15495 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1
Isosorbide SCHEMBL196416 1.00 THRB (1.00) THRBLMNAMAPTBCHEFUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006830-A1 POLYARYLETHER COPOLYMERS BASED ON DIOLS SUGAR ALCOHOLS BASF SE (DE) 2023-02-02 — — WO disclosed
WO-2022129139-A1 POLYESTER POLYOLS COMPRISING ISOSORBIDE, ISOIDIDE OR ISOMANNIDE-DERIVED UNITS BASF SE (DE) 2022-06-23 — — WO disclosed
WO-2020053079-A1 POLYARYLENE ETHER BASF SE (DE) 2020-03-19 — — WO disclosed
EP-2817314-B1 METHOD OF MAKING ISOIDIDE STICHTING WAGENINGEN RES (NL) 2017-04-19 — — EP disclosed
EP-2978769-B1 NOVEL PROCESS FOR PREPARING POLYOL GLYCOSIDES SOCIÉTÉ D'EXPLOITATION DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) 2017-03-29 — — EP disclosed
EP-3056496-A1 METHOD OF MAKING ISOIDIDE Stichting Dienst Landbouwkundig Onderzoek (NL) 2016-08-17 — — EP disclosed
US-9340552-B2 Method of making isoidide ARCHER DANIELS MIDLAND COMPANY (US) 2016-05-17 — — US disclosed
US-9340552-B2 Method of making isoidide ARCHER DANIELS MIDLAND COMPANY (US) 2016-05-17 — — US disclosed
US-20140371472-A1 METHOD OF MAKING ISOIDIDE STICHTING DIENST LANDBOUWKUNDI (NL) 2014-12-18 — — US disclosed
US-20140371472-A1 METHOD OF MAKING ISOIDIDE STICHTING DIENST LANDBOUWKUNDI (NL) 2014-12-18 — — US disclosed
WO-2013125950-A1 METHOD OF MAKING ISOIDIDE STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) 2013-08-29 — — WO disclosed
EP-1803773-B1 POLYMERIZABLE LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL FILM MADE FROM THE COMPOSITION NIPPON OIL CORP (JP) 2013-02-27 — — EP disclosed
US-20120249928-A1 LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2012-10-04 — — US disclosed
US-8199291-B2 Liquid crystal display device having polymer-stabilized blue phase liquid crystal layer and transparent films FUJIFILM CORPORATION (JP) 2012-06-12 — — US disclosed
US-20120092426-A1 CURABLE PHASE CHANGE INKS CONTAINING FUNCTIONALIZED ISOSORBIDES XEROX CORPORATION (US) 2012-04-19 — — US disclosed
US-20090322997-A1 LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2009-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371472-A1 METHOD OF MAKING ISOIDIDE SI, HSD11B2, HSD11B1 THRB 4597/4885LMNA 4552/4885MAPT 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback